Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 65% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Biomarin Enters Into Exclusive Worldwide License Agreement With Gc Biopharma And Hanmi Pharm For Investigational Next-Generation Enzyme Replacement Therapy

By Reuters News

Oct 29 (Reuters) - BioMarin Pharmaceutical Inc. BMRN.O:

  • BIOMARIN ENTERS INTO EXCLUSIVE WORLDWIDE LICENSE AGREEMENT WITH GC BIOPHARMA AND HANMI PHARM FOR INVESTIGATIONAL NEXT-GENERATION ENZYME REPLACEMENT THERAPY, ADDING A SECOND POTENTIAL TREATMENT FOR FABRY DISEASE

  • BIOMARIN PHARMACEUTICAL - TO MAKE $70 MILLION UPFRONT PAYMENT; GC AND HANMI ELIGIBLE FOR MILESTONES AND ROYALTIES

  • BIOMARIN PHARMACEUTICAL - GC AND HANMI ELIGIBLE FOR UP TO $405 MILLION IN MILESTONE PAYMENTS AND ROYALTIES

  • BIOMARIN PHARMACEUTICAL - TO ASSUME SOLE RESPONSIBILITY FOR HM15421/GC1134A OUTSIDE KOREA

  • BIOMARIN PHARMACEUTICAL - GC AND HANMI RETAIN COMMERCIALIZATION RIGHTS FOR HM15421/GC1134A IN KOREA

Further company coverage: BMRN.O

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.